ARVINDREM

Arvind Remedies Limited has informed the Exchange that Mr. G Ramachandran, Chief Financial Officer of the Company has resigned from the services of the company. Mr. S Balakrishnan, has taken over as Financial Controller of the Company with immediate effect.

Arvind Remedies Limited had informed the Exchange that the meeting of the Board of Directors of the Company is scheduled to be held on May 06, 2014 to consider and take on record the audited financial results of the company for the quarter and year ended March 31, 2014 and to recommend dividend if any on the equity shares of the company. The Company has now informed the Exchange that due to unavoidable circumstances, the above meeting is postponed.

Arvind Remedies Limited has informed the Exchange that on February 10, 2014 the commercial operation of the new unit of the Company at Kakkalur, Tiruvellore, Tamil Nadu for few products has been started.

Arvind Remedies Limited has submitted to the exchange the standalone financial results for the period ended 31-Dec-2013.

Arvind Remedies Limited has informed the Exchange that in the meeting convened on January 11, 2014 the shareholders have approved by passing special resolution, the proposed demerger of Irrungatukottai unit of the Company to Arvind Wellness Limited.

Arvind Remedies Limited has informed the Exchange regarding a press release dated November 18, 2013, titled, "Development of new Antiviral drug by Arvind Remedies Ltd".

Arvind Remedies Limited has submitted to the exchange the standalone financial results for the period ended 30-sep-2013.

Arvind Remedies Limited has informed the Exchange vide letter dated October 18, 2013 regarding "MoU to manufacture and market drugs with four educational Institutions - Patents drugs for Alzheimer, Parkinson and depression".

Arvind Remedies Limited has submitted to the Exchange vide letter dated October 05, 2013 a copy of disclosure pursuant to Regulation 13(4) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Arvind Remedies Limited has submitted to the Exchange a copy of the proceedings of the Annual General Meeting of the Members of the Company held on September 23, 2013.

Arvind Remedies Limited has informed the Exchange that Mr. K. V Narayan Director has resigned from the company with effect from July 23, 2013 and the same has been considered and accepted by the Board in its meeting held on August 07, 2013.

Arvind Remedies Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended June 30,2013.

Arvind Remedies Limited had informed the Exchange that the Company has fixed Book Closure from August 3, 2013 to August 7, 2013 for the purpose of payment of dividend & Annual General Meeting of the Company to be held on August 07, 2013. Arvind Remedies Limited has now informed the Exchange, vide letter dated July 24, 2013 that as per the decision of Board the date of Annual General Meeting has been revised and changed to September 23, 2013. In view of the above, the Revised Book Closure will be from September 19, 2013 to September 23, 2013 (both days inclusive) for the purpose of Annual Gener

Arvind Remedies Limited has informed the Exchange that Mr. V Santhana raman Director has resigned from the company with effect from July 03, 2013 and the same has been accepted.

Arvind Remedies Limited had informed the Exchange regarding the outcome of the Board Meeting held on May 15, 2013, including proposal for demerger of Irrungatukottal unit of the Company to Arvind Wellness Limited. The Company has now informed the Exchange that since the Irrungatukottai unit of the Company will have USFDA registration, to take care of the US strategy of business and to develop the US market for the products, the Company has set up a subsidiary Company in the name of Arvind Remedies LLC. in New Jersey, US.

Arvind Remedies Limited has informed the Exchange that the Company has fixed Book Closure from August 3, 2013 to August 7, 2013 for the purpose of payment of dividend & Annual General Meeting of the Company to be held on August 07, 2013.

Arvind Remedies Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended March 31,2013.

Arvind Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 15, 2013 has taken the following decisions : (1). Board approved the Demerger of Irungattukottai Unit of the Company into their Wholly Owned Subsidiary (WOS), Arvind Wellness Limited and fixed the appointed date as April 08, 2013. It was noted that the resultant Company (WOS) will be issuing preference share to the shareholders of ARL as a part of the demerger scheme. For the above purpose, the Board authorised Dr. B. Arvind Shah, Managing Director to sign, execute and file n

Arvind Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 15, 2013 has recommended a dividend of Re. 1 per equity share (including 2% special dividend due to Silver Jubilee year) of Rs.10 each, subject to the approval of the shareholders in the Annual General Meeting.

Arvind Remedies Limited has submitted to the Exchange vide letter dated March 25, 2013 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Arvind Remedies Limited has informed the Exchange that in the meeting of Board of Directors held on February 12, 2013, Board has appointed Mr. V. Santhanaraman as Additional Director of the Company with effect from February 12, 2013.

Arvind Remedies Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended December 31, 2012.

Arvind Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on January 24, 2013, approved to allot the 1,98,96,000 equity warrants of Rs.25 each to promoters and public (bodies corporate).

Arvind Remedies Limited has informed the Exchange that the following changes in the Board of Directors of the Company which the Board has taken note in its meeting : 1. Dr. Raghuveer Executive Director (Op) has resigned on December 03, 2012. 2. Mr. Sudhir Chandra has been appointed as Additional Director from December 18, 2012.

Arvind Remedies Limited has informed the Exchange vide letter dated December 27, 2012 that Mr. G. Ramachandran has joined the Company as Chief Financial Officer with effect from December 26, 2012.

Arvind Remedies Limited has informed the Exchange that in the Board meeting held on November 08, 2012 the Board has discussed and decided that the Company has plans to get registered its Irungatukottai unit as USFDA project. Company has received offer from M/s. Vensun Pharmaceuticals LLc in US for marketing tie up and for development of products with USFDA registration in the new plant at Irungatukottai, Dist. Kancheepuram Tamil Nadu and for supply to that country. Board authorized Managing Director to sign the MOU with the said company and to finalise the terms and conditions in this regard.

Arvind Remedies Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended September 30,2012.

Arvind Remedies Limited has informed the Exchange, vide letter dated October 19, 2012 that Mr. S. Sundara Raman, who was appointed as Chief Financial Officer of the Company resigned from the services.

Arvind Remedies Limited has submitted to the Exchange, vide letter dated October 04, 2012 a copy of Disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and Disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Arvind Remedies Limited has submitted to the Exchange a copy of the proceedings of the Annual General Meeting of the Members of the Company held on September 14, 2012.

Arvind Remedies Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended June 30,2012.

Arvind Remedies Limited had informed the Exchange that the Annual General Meeting of the Company will be held on July 31, 2012. Further, the Register of Members and Share Transfer Books of the Company shall remain closed from July 27, 2012 to July 31, 2012 (both days inclusive) for the purpose of Annual General Meeting and for payment of dividend that may be declared at the AGM. The company has now informed the Exchange that it has been decided by the Board to change the date of the AGM to September 14, 2012 and accordingly, to fix the revised dates for the book closure from September 11, 201

Arvind Remedies Limited has informed the Exchange that the following persons have been appointed as Directors of the Company during the current year : (1) Mr. Ankur Agarwal - Executive Director (Tech) w.e.f. April 18, 2012; (2) Dr. Raghuveer - Executive Director (Op) w.e.f. April 28, 2012.

Arvind Remedies Limited has informed the Exchange that the Annual General Meeting of the Company will be held on July 31, 2012. Further, the Register of Members and Share Transfer Books of the Company shall remain closed from July 27, 2012 to July 31, 2012 (both days inclusive) for the purpose of Annual General Meeting and for payment of dividend that may be declared at the AGM.